This segment focuses on the research, development, and commercialization of traditional Chinese medicines for treating cardiovascular and cerebrovascular diseases. Research and development activities include the formulation of new drugs and the improvement of existing ones, utilizing technologies such as extraction, purification, and formulation of herbal ingredients. The segment addresses conditions like stroke, heart disease, and hypertension, aiming to improve patient outcomes through effective and safe treatments. Market positioning is strong in China, with a competitive advantage in traditional Chinese medicine expertise. Future opportunities include expanding into international markets and developing new formulations. Regulatory aspects involve compliance with Chinese pharmaceutical regulations and clinical trials to demonstrate efficacy and safety. Partnerships may include collaborations with hospitals and research institutions for clinical trials and product development.

This segment concentrates on the development and commercialization of Chinese medicines for respiratory ailments. Research and development efforts involve the study of herbal compounds and their effects on respiratory conditions, including asthma, bronchitis, and pneumonia. The company utilizes advanced extraction and formulation techniques to create effective treatments. The segment aims to improve the quality of life for patients suffering from respiratory diseases by providing accessible and effective medications. Market positioning is primarily within China, with a focus on traditional Chinese medicine. Future growth potential lies in expanding the product portfolio and exploring new therapeutic applications. Regulatory compliance is crucial, requiring adherence to Chinese pharmaceutical standards and clinical trials to validate product efficacy and safety. Partnerships may involve collaborations with respiratory specialists and research institutions to enhance product development and clinical trials.

This segment is dedicated to the research, development, and commercialization of traditional Chinese medicines for orthopedic conditions. Research and development activities focus on the formulation of herbal remedies for musculoskeletal disorders, such as arthritis, bone fractures, and joint pain. The company employs advanced extraction and formulation techniques to create effective treatments. The segment aims to improve patient mobility and reduce pain through the use of traditional Chinese medicine. Market positioning is primarily within China, with a focus on traditional Chinese medicine. Future growth potential lies in expanding the product portfolio and exploring new therapeutic applications. Regulatory compliance is crucial, requiring adherence to Chinese pharmaceutical standards and clinical trials to validate product efficacy and safety. Partnerships may involve collaborations with orthopedic specialists and research institutions to enhance product development and clinical trials.